SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950170-24-084248
Filing Date
2024-07-17
Accepted
2024-07-17 16:05:42
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 s-3_resale_for_pipe.htm S-3 494398
2 EX-5.1 awh-ex5_1.htm EX-5.1 24251
3 EX-23.1 awh-ex23_1.htm EX-23.1 5202
4 EX-FILING FEES awh-exfiling_fees.htm EX-FILING FEES 46491
5 GRAPHIC img166079011_0.jpg GRAPHIC 933834
6 GRAPHIC img170348524_0.jpg GRAPHIC 4590
  Complete submission text file 0000950170-24-084248.txt   1847480
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Filer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-280848 | Film No.: 241122248
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)